Griptha Putra Persada Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Griptha Putra Persada Tbk. trades at Rp59 (market cap 60B, 661.3K 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,520 (market cap 11.18T, 613K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 186.3× Griptha Putra Persada Tbk.'s market cap, and Griptha Putra Persada Tbk. is more actively traded (661.3K versus 613K). Which is the better fit depends on your goals.
| GRPH | TSPC | |
|---|---|---|
Market Cap | 60B | 11.18T |
Volume | 661.3K | 613K |
Lot | 6.61K | 6.13K |
Turnover | 39.67M | 1.54B |
Average Price | 59.99 | 2,511.52 |
Value | 39.67M | 1.54B |
Indicative Equilibrium Price | 59 | 2,520 |
Indicative Equilibrium Volume | 640 | 17 |
Trailing returns across standard periods
Latest headlines on both assets
PT Griptha Putra Persada Tbk (the Company), was established based on Notarial Deed No. 26 dated April 14, 2010 of Drs. Ika Slamet Riyono, S.H., notary in Kudus. The Company started its commercial operation in July 1, 2015. The Company’s immediate parent company is PT Mulia Jaya Palma and the ultimate controlling shareholder of the Company is Samuel Jeffrey Christiawan Soegeng.
Read more on GRPH →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →